In 1967, the term "respirator lung" was coined to describe the diffuse alveolar infiltrates and hyaline membranes that were found on postmortem examination of patients who had undergone mechanical ventilation.This mechanical ventilation can aggravate damaged lungs and damage normal lungs. In recent years, Various ventilation strategies have been used to minimize lung injury, including low tide volume, higher PEEPs, recruitment maneuvers and high-frequency oscillatory ventilation. which have been proved to reduce the occurrence of lung injury. In 2012,Needham et al. proposed a kind of lung protective mechanical ventilation, and their study showed that limited volume and pressure ventilation could significantly improve the 2-year survival rate of patients with acute lung injury.Volume controlled ventilation is the most commonly used method in clinical surgery at present.Volume controlled ventilation(VCV) is a time-cycled, volume targeted ventilation mode, ensures adequate gas exchange. Nevertheless, during VCV, airway pressure is not controlled.Pressure controlled ventilation(PCV) can ensure airway pressure,however minute ventilation is not guaranteed.Pressure controlled ventilation-volume guarantee(PCV-VG) is an innovative mode of ventilation utilizes a decelerating flow and constant pressure. Ventilator parameters are automatically changed with each patient breath to offer the target VT without increasing airway pressures. So PCV-VG has the advantages of both VCV and PCV to preserve the target minute ventilation whilst producing a low incidence of barotrauma pressure-targeted ventilation. Current studies on PCV-VG mainly focus on thoracic surgery, bariatric surgery and urological surgery, and the research indicators mainly focus on changes in airway pressure and intraoperative oxygenation index.The age of patients undergoing laparoscopic colorectal cancer resection is generally higher, the cardiopulmonary reserve function is decreased, and the influence of intraoperative pneumoperitoneum pressure and low head position increases the incidence of intraoperative and postoperative pulmonary complications.Whether PCV-VG can reduce the incidence of intraoperative lung injury and postoperative pulmonary complications in elderly patients undergoing laparoscopic colorectal cancer resection, and thereby improve postoperative recovery of these patients is still unclear.
One hundred patients undergoing elective laparoscopic colorectal cancer resection (age \> 65 years old, body mass index(BMI)18-30 kg/m2, American society of anesthesiologists(ASA )grading Ⅰ - Ⅲ ) will be randomly assigned to volume control ventilation(VCV)group and pressure controlled ventilation-volume guarantee(PCV-VG)group.General anesthesia combined with epidural anesthesia will be used to both groups. Ventilation settings in both groups are VT 8 mL/kg,inspiratory/expiratory (I/E) ratio 1:2,inspired oxygen concentration (FIO2) 0.5 with air,2.0 L/min of inspiratory fresh gas flow,positive end-expiratory pressure (PEEP) 0 millimeter of mercury (mmHg),respiratory rate (RR) was adjusted to maintain an end tidal CO2 pressure (ETCO2) of 35 -45 mmHg. In operation dates will be collected at the following time points: preanesthesia, 1 hour after pneumoperitoneum,2 hours after pneumoperitoneum ,30 minutes after admission to post-anaesthesia care unit (PACU) .The dates collected or calculated are the following:1)peak airway pressure,plate airway pressure, mean inspiratory pressure, dynamic compliance, RR,Exhaled VT andETCO2,2) Arterial blood gas analysis: arterial partial pressure of oxygen (PaO2), arterial partial pressure of carbon dioxide (PaCO2),power of hydrogen(PH), and oxygen saturation (SaO2),3) Oxygenation index (OI) calculation; PaO2/FIO2, 4) Ratio of physiologic dead-space over tidal volume(Vd/VT) (expressed in %) was calculated with Bohr's formula ; Vd/VT = (PaCO2 - ETCO2)/PaCO2,5) Hemodynamics: heart rate, mean arterial pressure (MAP),and central venous pressure (CVP),6) lung injury markers :Interleukin 6(IL6),Interleukin 8(IL8),Clara cell protein 16(CC16),Solution advanced glycation end products receptor(SRAGE),tumor necrosis factor α(TNFα) . Investigators will collect the following dates according to following-up after surgery: the incidence of postoperation pulmonary complications(PPC) based on PPC scale within seven days , incidence of pneumonia within seven days after surgery,incidence of atelectasis within seven days after surgery,length of hospital days after surgery, the incidence of postoperative unplanned admission to ICU, the incidence of operation complications within 7 days after surgery, the incidence of postoperative systematic complications within 7 days after surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
100
patients will be allocated to pressure-controlled ventilation-volume guaranteed in operation
patients will be allocated to pressure-controlled ventilation volume guaranteed in operation
Six Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China
RECRUITINGoccurrence rate of Oxygenation index≤300mmHg
Oxygenation index(OI)=PaO2/FiO2
Time frame: 10minutes before anesthesia,1 hour after pneumoperitoneum,2 hour after pneumoperitoneum,30 minutes after after extubation
Occurrence rate of pulmonary complications
Pulmonary complications were assessed using the Postoperation Pulmonary complication ( PPC) scale,The scale is divided into four grades, with 0 indicating no pulmonary complications and 1 to 4 indicating increasingly severe pulmonary complications.
Time frame: Day 0 to 7 after surgery
incidence of pneumonia
record the occurrence rate of pneumonia after surgery
Time frame: Day 0 to 7 after surgery
incidence of pulmonary atelectasis
record the occurrence rate of pulmonary atelectasis after surgery
Time frame: Day 0 to 7 after surgery
peak airway pressure
Peak airway Pressure(Ppeak, cm H2O)
Time frame: through mechanical ventilation,average of 3 hours
Plateau airway pressure
Plateau airway pressure(Pplat, cm H2O)
Time frame: through mechanical ventilation,average of 3 hours
Static lung compliance
Static lung compliance (Csta, ml/cm H2O) = Vt/ (Pplat-PEEP)
Time frame: through mechanical ventilation,average of 3 hours
Dynamic lung compliance
Dynamic lung compliance (Cdyn , ml/cm H2O)= Vt/ (Ppeak-PEEP)
Time frame: through mechanical ventilation,average of 3 hours
Arterial partial pressure of oxygen
Arterial partial pressure of oxygen (PaO2, mmHg)
Time frame: 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation
assessing change of Alveolar-arterial oxygen tension difference
Alveolar-arterial oxygen tension difference (mmHg)
Time frame: 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation
assessing change of Respiratory index
Fraction of inspired oxygen (FiO2); Respiratory index (RI) =Ratio of alveolar-arterial oxygen tension difference to FiO2
Time frame: 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation
assessing change of Alveolar dead space fraction
Arterial carbon dioxide partial pressure (PaCO2); partial pressure of carbon dioxide in endexpiratory gas (PetCO2); Alveolar dead space fraction (Vd/Vt)=(PaCO2-PetCO2)/ PaCO2;
Time frame: 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum,30 minutes after extubation
assessing change of lactic acid
lactate ( LAC), mmol/L
Time frame: 10 minutes before anesthesia, 1 hour after pneumoperitoneum, 2 hours after pneumoperitoneum, 30 minutes after extubation
assessing change of Advanced glycation end products receptor
Advanced glycation end products receptor (RAGE, pg/ml)
Time frame: 10 minutes before anesthesia,30 minutes after extubation
assessing change of Tumor Necrosis Factor alpha
Tumor Necrosis Factor alpha (TNF-α, pg/ml)
Time frame: 10 minutes before anesthesia,30 minutes after extubation
assessing change of Interleukin 6
Interleukin 6 (IL-6, pg/ml)
Time frame: 10 minutes before anesthesia,30 minutes after extubation
assessing change of Interleukin 8
Interleukin 8 (IL-8, pg/ml)
Time frame: 10 minutes before anesthesia,30 minutes after extubation
assessing change of Clara cell protein 16,
Clara cell protein 16,
Time frame: 10 minutes before anesthesia,30 minutes after extubation
The occurrence rate of hypoxemia in PACU
The occurrence rate of hypoxemia (SPO2\<90% or PaO2\<60 mmHg) in PACU
Time frame: 30 minutes after extubation
Occurrence rate of operation complications
abdominal abscess, anastomotic fistula, bleeding and the incidence of reoperation within 7 days
Time frame: within 7 days after operation
Occurrence rate of Systemic complications
Systemic complications including sepsis and septic shock
Time frame: within 7 days after surgery
Antibiotic dosages
record the Antibiotic dosages within 7 days after surgery
Time frame: within 7 days after surgery
incidence of Unplanned admission to ICU
Unplanned admission to ICU within 30 days after surgery
Time frame: within 30 days after surgery
Length of ICU stay within 30 days after surgery
Length of ICU stay within 30 days after surgery
Time frame: within 30 days after surgery
Length of hospital stay within 30 days after surgery
Length of hospital stay within 30 days after surgery
Time frame: within 30 days after surgery
Death from any cause
Death from any cause 30 days after surgery
Time frame: within 30 days after surgery
The occurrence rate of hypoxemia after surgery
The occurrence rate of hypoxemia (SPO2\<90% or PaO2\<60 mmHg) after surgery
Time frame: within 7 days after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.